Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Zbinden

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Cardiology and Therapy|November 27, 2016
Infective Endocarditis: How Do We Currently Interpret the Duke Minor Criterion "Predisposing Heart Condition" in Native Valves?Annina Elisabeth Büchi, Mario Hoffmann, Stephan Zbinden, et al.
Journal of the American College of Cardiology|November 1, 2005
Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery diseaseStephan Zbinden, Rainer Zbinden, Pascal Meier, et al.
Circulation|April 23, 2003
Is there functional collateral flow during vascular occlusion in angiographically normal coronary arteries?Kerstin Wustmann, Stephan Zbinden, Stephan Windecker, et al.
Swiss Medical Weekly|November 16, 2018
The Duke minor criterion "predisposing heart condition" in native valve infective endocarditis - a systematic reviewAnnina Büchi, Mario Hoffmann, Stephan Zbinden, et al.
Annual Review of Pathology|November 28, 2007
Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanismsMichael A Laflamme, Stephan Zbinden, Stephen E Epstein, et al.
Chest|October 11, 2016
A 43-Year-Old Man With Daytime Sleepiness and a Heart MurmurChristian M Horvath, Stephan Zbinden, Sebastian R Ott, et al.
Cardiovascular Research|January 8, 2008
Cardiovascular risk factors impair native collateral development and may impair efficacy of therapeutic interventionsTim Kinnaird, Eugenio Stabile, Stephan Zbinden, et al.
Cardiology|October 15, 2003
Exercise-induced human coronary collateral function: quantitative assessment during acute coronary occlusionsTilmann Pohl, Kerstin Wustmann, Stephan Zbinden, et al.
Coronary Artery Disease|April 9, 2005
Tumour necrosis factor-alpha and interleukin-6 release during primary percutaneous coronary intervention for acute myocardial infarction is related to coronary collateral flowRoby D Rakhit, Christian Seiler, Kerstin Wustmann, et al.
Journal of the National Cancer Institute|January 12, 2012
Targeted therapies for renal cell carcinoma: review of adverse event management strategiesTim Eisen, Cora N Sternberg, Caroline Robert, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Cardiology and Therapy|November 27, 2016
Infective Endocarditis: How Do We Currently Interpret the Duke Minor Criterion "Predisposing Heart Condition" in Native Valves?Annina Elisabeth Büchi, Mario Hoffmann, Stephan Zbinden, et al.
Journal of the American College of Cardiology|November 1, 2005
Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery diseaseStephan Zbinden, Rainer Zbinden, Pascal Meier, et al.
Circulation|April 23, 2003
Is there functional collateral flow during vascular occlusion in angiographically normal coronary arteries?Kerstin Wustmann, Stephan Zbinden, Stephan Windecker, et al.
Swiss Medical Weekly|November 16, 2018
The Duke minor criterion "predisposing heart condition" in native valve infective endocarditis - a systematic reviewAnnina Büchi, Mario Hoffmann, Stephan Zbinden, et al.
Annual Review of Pathology|November 28, 2007
Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanismsMichael A Laflamme, Stephan Zbinden, Stephen E Epstein, et al.
Chest|October 11, 2016
A 43-Year-Old Man With Daytime Sleepiness and a Heart MurmurChristian M Horvath, Stephan Zbinden, Sebastian R Ott, et al.
Cardiovascular Research|January 8, 2008
Cardiovascular risk factors impair native collateral development and may impair efficacy of therapeutic interventionsTim Kinnaird, Eugenio Stabile, Stephan Zbinden, et al.
Cardiology|October 15, 2003
Exercise-induced human coronary collateral function: quantitative assessment during acute coronary occlusionsTilmann Pohl, Kerstin Wustmann, Stephan Zbinden, et al.
Coronary Artery Disease|April 9, 2005
Tumour necrosis factor-alpha and interleukin-6 release during primary percutaneous coronary intervention for acute myocardial infarction is related to coronary collateral flowRoby D Rakhit, Christian Seiler, Kerstin Wustmann, et al.
Journal of the National Cancer Institute|January 12, 2012
Targeted therapies for renal cell carcinoma: review of adverse event management strategiesTim Eisen, Cora N Sternberg, Caroline Robert, et al.
Pageof 2